|
APPL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22044604925031E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.56448245656338E-12 |
| Normal-vs-Stage2 |
4.82819999980677E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
4.996000E-01 |
| Stage1-vs-Stage3 |
1.93426999999247E-05 |
| Stage1-vs-Stage4 |
3.50840000000741E-05 |
| Stage2-vs-Stage3 |
7.062300E-02 |
| Stage2-vs-Stage4 |
6.848300E-02 |
| Stage3-vs-Stage4 |
9.423400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
6.46882547528094E-12 |
| Normal-vs-Asian |
9.377900E-03 |
| Caucasian-vs-AfricanAmerican |
3.428000E-01 |
| Caucasian-vs-Asian |
5.472400E-01 |
| AfricanAmerican-vs-Asian |
3.236600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.94910754203192E-12 |
| Male-vs-Female |
1.566160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.213000000444E-07 |
| Normal-vs-Age(41-60Yrs) |
1.66711089377714E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.98809865739713E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.920200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.363200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.256220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.394800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.158100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.331700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.467900E-02 |
| Normal-vs-Grade 2 |
1.73789982405026E-10 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
1.718810E-01 |
| Grade 1-vs-Grade 3 |
5.818900E-04 |
| Grade 1-vs-Grade 4 |
1.71902999999141E-05 |
| Grade 2-vs-Grade 3 |
1.168190E-04 |
| Grade 2-vs-Grade 4 |
5.27410000117357E-08 |
| Grade 3-vs-Grade 4 |
1.031980E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.37660044158872E-10 |
| Normal-vs-ccB subtype |
1.63191682389652E-12 |
| ccA subtype-vs-ccB subtype |
2.340000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63014046705712E-12 |
| Normal-vs-N1 |
2.42219999946336E-07 |
| N0-vs-N1 |
3.128200E-01 |
|
|
